Protagonist Therapeutics shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Kennedy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $10M | 290k | 34.65 |
| 2024-03-31 | $8.6M | 298k | 28.93 |
| 2023-12-31 | $7.0M | 305k | 22.93 |
| 2023-09-30 | $5.3M | 320k | 16.68 |
| 2023-06-30 | $11M | 404k | 27.62 |
| 2023-03-31 | $7.6M | 331k | 23.00 |
| 2022-12-31 | $3.8M | 350k | 10.91 |
| 2022-09-30 | $835k | 99k | 8.43 |
| 2022-06-30 | $784k | 99k | 7.91 |
| 2022-03-31 | $2.3M | 97k | 23.68 |
| 2021-12-31 | $3.6M | 105k | 34.20 |
| 2021-09-30 | $2.0M | 112k | 17.72 |
| 2021-06-30 | $3.2M | 72k | 44.88 |
| 2021-03-31 | $2.0M | 76k | 25.90 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management